Table 2.
Nups and other nucleocytoplasmic transport proteins in premature aging and neurodegeneration.
| Disease | Pathogenic macromolecules of interest | Experimental systems (excluding non-mammalian models) | Mislocalized or coaggregated proteins | Reference |
|---|---|---|---|---|
| HGPS | Progerin | Patient fibroblasts | Tpr and Ran | Kelley et al., 2011 |
| Nup153 and Transportin-1 | Larrieu et al., 2018 | |||
| ALS | N/A | iPSC-derived neurons and patient brains | Nup107, Nup205, Ran, and RanGAP1 | Zhang et al., 2015 |
| N/A | iPSC-derived neurons | RCC1 | Jovicic et al., 2015 | |
| (GR)n and (PR)n | HEK293T | Nup155, Nup205, Ran, RanGAP1, and several karyopherins | Lee et al., 2016 | |
| (GA)n | Mouse models | Pom121 and RanGAP1 | Zhang et al., 2016 | |
| (PR)n | Recombinant proteins | Nup98 and Nup54 | Shi et al., 2017 | |
| Arginine-containing DPRs | HEK293T lysate | >20 Nups and transport factors | Hayes et al., 2020 | |
| (G4C2)n and (G2G4)n RNAs | iPSC-derived neurons and patient brains | Pom121, Ndc1, Nup210, Tpr, Nup50, Nup98, Nup107,and Nup133 | Coyne et al., 2020 | |
| TDP-43 | Neuro-2a cell line and patient brains | >20 Nups and transport factors | Chou et al., 2018 | |
| Huntington’s | Polyglutamine- expanded |
Mouse models, iPSC-derived neurons, and patient brains | Gle1 and RanGAP1 | Gasset-Rosa et al., 2017 |
| HTT | Mouse models, iPSC-derived neurons, and patient brains | Nup62, Nup88, Ran, and RanGAP1 | Grima et al., 2017 | |
| Alzheimer’s | Tau | Mouse models and patient brains | Nup98 and Ran | Eftekharzadeh et al., 2018 |